| Market Capitalization (Millions $) |
65,982 |
| Shares
Outstanding (Millions) |
1,495 |
| Employees |
59,000 |
| Revenues (TTM) (Millions $) |
20,616 |
| Net Income (TTM) (Millions $) |
3,559 |
| Cash Flow (TTM) (Millions $) |
723 |
| Capital Exp. (TTM) (Millions $) |
866 |
Business Description
Company Profile: Boston Scientific Corporation
Overview:
Boston Scientific Corporation is a global leader in the development, manufacturing, and marketing of medical devices. Founded in 1979, the company focuses on advancing the practice of less-invasive medicine through a comprehensive range of innovative products, technologies, and services within various interventional medical specialties, including but not limited to interventional cardiology, peripheral interventions, neurovascular intervention, electrophysiology, vascular surgery, endoscopy, oncology, urology, and gynecology.
Product Offerings:
Boston Scientific’s product portfolio includes devices that are typically inserted into the human body through natural openings or small incisions, allowing for minimally invasive diagnosis and treatment of a wide array of medical conditions. These products significantly enhance patient outcomes by providing alternatives to traditional surgery, improving overall quality of life for patients.
The company is particularly recognized for its leadership in the interventional cardiology market, where its advanced coronary stent offerings are vital in treating coronary artery disease. Boston Scientific is dedicated to improving coronary stent performance by researching and developing innovative solutions to address challenges like in-stent restenosis.
Business Structures:
Boston Scientific operates through two primary business groups:
1. Cardiovascular: This group develops products and technologies utilized in interventional cardiology, peripheral interventions, vascular surgery, electrophysiology, and neurovascular procedures.
2. Endosurgery: This group focuses on oncology, endoscopy, urology, and gynecology.
The company launched a master branding initiative to unify its brand identity, transitioning from a collection of divisional brands to a single, cohesive entity. This initiative aims to enhance recognition and brand equity for Boston Scientific as a whole.
Market Presence:
The company sells its products to over 10,000 hospitals, clinics, outpatient facilities, and medical offices globally, mitigating dependency on any single institution. Additionally, Boston Scientific distributes select products for third-party manufacturers, including introducer sheaths, guidewires, and acellular tissue used in urology and gynecology.
International Operations:
Boston Scientific is structured into three geographic segments: Europe, Japan, and Inter-Continental, enabling it to cater to regional needs while maintaining strong global outreach.
Competition:
Boston Scientific faces intense competition across its product lines from various companies, many of which possess significant financial and marketing resources. Key competitors include Abbott Laboratories, Cook, Inc. Guidant Corporation (and its subsidiary Advanced Cardiovascular Systems, Inc.), Johnson & Johnson (through its subsidiary Cordis Corporation), and Medtronic, Inc. (including its subsidiary Medtronic AVE, Inc.). The competitive landscape also includes numerous companies specializing in specific markets or offering limited product lines.
Conclusion:
As a pioneer in the medical device industry, Boston Scientific Corporation continues to push the boundaries of innovation in less-invasive medical technology, aiming to improve patient outcomes and provide healthcare professionals with advanced therapeutic options.
Company Address: 300 Boston Scientific Way Marlborough 1752 MA
Company Phone Number: 683-4000 Stock Exchange / Ticker: NYSE BSX
|
32.69 %